02November

Embark and Novo Nordisk enter collaboration to discover novel therapeutics for o ... Read more

01November

Novo Nordisk's operating profit decreased by 6% in Danish kroner and increased b ... Read more

31October

Novo Nordisk expands its biopharm business with the acquisition of the US and Ca ... Read more

26October

Oral semaglutide demonstrates statistically significant reductions in HbA1c and ... Read more

15November

Novo Nordisk A/S - Share repurchase programme ... Read more

06November

Trading in Novo Nordisk shares by board members, executives and associated perso ... Read more

05November

Novo Nordisk A/S - Share repurchase programme ... Read more

05November

Novo Nordisk A/S purchases B shares worth DKK 1,262 million from Novo Holdings A ... Read more

05December

Danske Bank Winter Seminar, Copenhagen

06December

Citi Global Healthcare Conference, New York

14November

Societe Generale European ESG/SRI Conference, Paris

01November

Financial statement for the first nine months of 2018,

 

 

 

Investors

 
Share information


Take an advanced view of the Novo Nordisk share

 
Annual Report 2017 


Click here to find further information

 
Q3 2018 financial results


Novo Nordisk at a glance


Private shareholders


See relevant content for private investors



IR material


Download relevant Investor Relations material



Contacts



Subscriptions


Sign up to receive company announcements.


ADA investor and analyst event